Fifteen-year results from clinical trial suggest that follicular lymphoma is curable
Medical Xpress
February 26, 2026
AI-Generated Deep Dive Summary
Fifteen-year results from a clinical trial have brought exciting news for those affected by follicular lymphoma. Once considered incurable in its advanced stages, particularly compared to other forms of lymphoma, the disease now shows promising signs of being treatable with long-term success. A comprehensive analysis of long-term data from patients treated years ago with standard therapies—immunotherapy combined with a chemotherapy regimen known as CHOP—suggests that many individuals can be considered cured after 15 years.
This groundbreaking study, published in the journal JAMA Oncology, revises previous assumptions about follicular lymphoma. Advanced-stage cases were previously deemed incurable, often leading to discouraging prognoses for patients and their families. However, by examining data from patients who underwent treatment with immunotherapy and CHOP chemotherapy, researchers found that a significant number achieved long-term survival without
Verticals
healthmedical
Originally published on Medical Xpress on 2/26/2026